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The Lyme disease spirochete, Borrelia burgdorferi, inhabits the gut lumen of the tick vector. At this location
the spirochete is exposed to host blood when a tick feeds. We report here on studies that were done with normal
and complement-deficient (C3-knockout) mice to determine if the host complement system killed spirochetes
within the vector. We found that spirochete numbers within feeding nymphs were not influenced by comple-
ment, most likely because host complement was inactivated within the vector. The Lyme disease outer surface
protein A (OspA) vaccine is a transmission-blocking vaccine that targets spirochetes in the vector. In exper-
iments with mice hyperimmunized with OspA, complement was not required to kill spirochetes within nymphs
and to block transmission from nymphs to the vaccinated host. However, host complement did enhance the
ability of OspA antibody to block larvae from acquiring spirochetes. Thus, the effects of OspA antibody on
nymphal transmission and larval acquisition appear to be based on different mechanisms.
Lyme disease spirochetes (Borrelia burgdorferi) are extracel-
lular bacteria that cause systemic infections in vertebrate hosts.
In the tick vector, infections are mainly confined to the lumen
of the gut (27). At this location the bacteria are exposed to host
blood whenever a tick feeds. Here we report on studies to
determine if spirochetes within the tick are sensitive to host
complement proteins in the blood meal.
B. burgdorferi grown in culture activates complement even in
the absence of specific antibodies against Borrelia, and com-
plement protein C3b binds to the bacterial surface (3, 4, 21,
34). The B. burgdorferi ERP (OspEF-related protein) family of
outer membrane proteins binds to factor H and factor H-like
protein 1 (FHL-1), which are host serum proteins that inacti-
vate C3b (14, 15, 30). Thus, spirochetes appear to resist the
bactericidal effects of activated complement by binding to host
proteins that inactivate C3b. Many ERPs are expressed in the
mammalian host and are likely to play a role in protecting
B. burgdorferi from complement in the mammal (30). It is not
known if spirochetes utilize special mechanisms for protecting
themselves from complement in the tick blood meal.
Active host complement in the tick blood meal could have a
profound impact on B. burgdorferi within ticks. Complement in
the blood meal may reduce the number of spirochetes within
the tick gut, and this, in turn, may lower the number of in-
fected ticks as well as the ability of infected ticks to transmit
spirochetes. Thus, spirochetes within the tick may have evolved
specific mechanisms such as the expression of particular ERPs
to escape from complement in the blood meal (30). It is also
possible that complement may be inactivated by factors pro-
duced by the feeding tick and that spirochetes may not require
special mechanisms for protecting themselves from host com-
plement in the tick gut (25, 33, 36).
Studies of the fate of host complement in the tick may also
reveal new information about the OspA Lyme disease vaccine.
The OspA protein is primarily expressed by spirochetes in the
tick gut, where it functions as a receptor for anchoring spiro-
chetes to the gut epithelium (20). The OspA vaccine selectively
targets spirochetes expressing OspA in the tick gut and blocks
transmission from the tick to the host (9). OspA antibodies
also prevent uninfected larval ticks from acquiring an infection
from infected mice by targeting spirochetes as they enter the
tick and upregulate the expression of OspA (8). It is not known
if active complement in the blood meal is required for the
effects of OspA antibody on Borrelia within ticks.
Here we describe studies with normal mice and transgenic
mice without a functional complement system to understand
the influence of host complement on B. burgdorferi within
feeding ticks. The studies were done both in the absence and in
the presence of specific antibody against B. burgdorferi.
MATERIALS AND METHODS
B. burgdorferi and culture conditions. A clonal population of low-passage-
number Westchester strain B. burgdorferi sensu stricto grown in Barbour-Stoen-
ner-Kelly II medium at 33°C to mid-log density (1  107 to 3  107 cells/ml) was
used in this study.
Mice and ticks. Transgenic C57BL/6 mice deficient in component C3 of the
complement system (kindly provided by M. C. Carroll, Center for Animal Re-
sources and Comparative Medicine, Harvard Medical School, Boston, Mass.)
and wild-type (WT) C57BL/6 mice were bred and used for the experiments (35).
The mice were caged individually and provided with antibiotic-free food and
water ad libitum.
Ixodes scapularis ticks infected with the Westchester strain of B. burgdorferi
were raised as described previously (23) and used for various experiments in this
study.
Estimating spirochete number within nymphs. Westchester strain-infected
nymphal ticks were allowed to feed on complement-deficient (CD) and comple-
ment-sufficient mice. Nymphs were then removed with fine forceps at 48, 60, and
72 h into the blood meal. The spirochete load within individual nymphs that had
not fed (0-h point) or fed for 48, 60, and 72 h was assessed by immunofluores-
cence staining of individual tick homogenates as described below. Four or five
nymphs were used for each time point. Nymphs were homogenized individually
in 40 l of phosphate-buffered saline (PBS) in 0.5-ml Eppendorf tubes with
disposable pestles (Nalgene Nunc International, Naperville, Ill.). Five microliters
of the homogenates was spotted on silylated slides (PGC Scientifics, Frederick,
Md.). The spots were air dried, acetone fixed, blocked with 5% fetal calf serum
in PBS (pH 7.2), and incubated with fluorescein isothiocyanate (FITC)-conju-
gated anti-Borrelia antibodies for 1 h at room temperature. Following incubation,
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the slides were washed three times with PBS, air dried, and mounted with
Aqua-Polymount (Polysciences Inc., Warrington, Pa.). The number of spiro-
chetes in 10 fields (400 magnification) was counted, and this number was used
to estimate the mean number of spirochetes per single 400 microscope field.
The total count in 10 fields ranged from a low of 5 spirochetes (0-h point) to a
high of 1,404 spirochetes (72-h point). A 5-l spot on the slide has an area
equivalent to 49 400 microscope fields. The number of spirochetes in each
nymph was calculated by the following equation: (mean number of bacteria in
single 400 field)  (49 fields)  (40 l/5 l).
Immunization and challenge experiments. Groups of CD and complement-
sufficient mice were injected subcutaneously with 20 g of OspA glutathione
S-transferase (GST) fusion protein in complete Freund’s adjuvant. Control mice
received similar amounts of GST. Mice were boosted with 10 g of OspA-GST
in incomplete Freund’s adjuvant twice at 2-week intervals after the first dose.
Two weeks after the final boost the mice were bled to measure OspA antibody
titer and then challenged with five to seven infected nymphs per mouse. Mice
were killed 3 weeks after the nymphs had fallen off and tested for Borrelia
infection by serology (Western blotting) and organ culture in Barbour-Stoenner-
Kelly II medium. Infected nymphal ticks that had fed to repletion on the OspA-
GST- and GST-immunized mice were homogenized individually in PBS, and the
spirochete load in the nymphs was assessed by immunofluorescence staining as
described above.
Acquisition of spirochetes by larval ticks. CD and complement-sufficient mice
were infected with the Westchester strain of B. burgdorferi by infected nymphal
tick feeding. Infection was confirmed by serology with Western blotting. Infected
CD and complement-sufficient mice were passively immunized with hyperim-
mune OspA antibodies raised in CD mice as described above. Control mice were
passively immunized with control serum raised against GST. Mice in the exper-
imental and control groups received 100 l of hyperimmune serum subcutane-
ously and 100 l intraperitoneally. Twenty-four hours after passive immuniza-
tion, the mice were anesthetized with ketamine-xylazine, and approximately 100
larvae were placed on each mouse. The larvae that had fed to repletion were
collected and stored in groups of 20 in a humid chamber. Fifteen larvae from
each mouse were tested individually for spirochetes by immunofluorescence 2
weeks after the blood meal.
In vitro complement assays. Sera for bactericidal assays were collected from
normal (normal mouse serum [NMS]) and CD mice (CD mouse serum [CDS])
into red-top Vacutainer tubes. The blood was allowed to clot at 37°C for 30 min.
Subsequently, serum was separated by centrifuging the clotted blood at 4°C,
clarified by passage through 0.45-m-pore-size syringe filters (Millipore), and
stored in aliquots at 70°C. A pool of sera from six mice was used for the assays.
Nymphal tick gut contents (TGC) for complement assays were collected by
allowing uninfected nymphs to feed on CD and complement-sufficient mice. At
72 h into the blood meal the nymphs were removed with fine forceps. The
nymph’s surface was disinfected with 70% ethanol for 5 min. The exoskeleton
was punctured with a 27-gauge needle, and the gut contents were collected at 4°C
as follows. The nymph was gently pressed, and gut content was collected through
the puncture site into gelatin vernol buffer (GVB) with 2 mM phenylmethylsul-
fonyl fluoride at 4°C. Contents from two nymphs were collected into 10 l of
GVB and frozen immediately at 80°C.
The serum bactericidal assays were performed as described previously with
slight modifications (13). Spirochetes (Westchester strain) from culture or puri-
fied from feeding nymphs (24) were centrifuged at 2,040  g for 15 min at room
temperature, and the cell pellet was washed once with minimal essential medium
(MEM; GIBCO BRL, Rockville, Md.). The cells were adjusted to the desired
concentration in MEM. In each assay 1.2  106 spirochetes were used in a final
volume of 100 l. In each experiment spirochetes (cultured or tick derived) were
resuspended in MEM alone as well as with different sources of specific antibody
and complement. A hyperimmune Borrelia antiserum raised in CD mice was used
as a source of specific antibody against spirochetes. Initially the bacteria were
incubated with the hyperimmune serum (1:4,000 dilution) at 37°C for 15 min.
Next, the following sources of serum were added to different tubes: NMS,
heat-inactivated NMS (56°C for 30 min), CDS, gut contents from nymphs fed on
WT mice (WT TGC), and gut contents of nymphs fed on CD mice (CD TGC).
All the serum sources were added to a final concentration of 10%. When equal
volumes of mouse serum and TGC were probed for C3 on a Western blot, the
NMS sample yielded a signal that was approximately four times more intense
than the WT TGC (see Fig. 2). Thus, in the in vitro assays we used four times
more TGC (40 l) than NMS (10 l) to ensure that we had similar levels of
serum protein in each assay. The reaction mixtures were incubated for 2 h at 37C
in a 2% CO2 atmosphere. At the end of the incubation period the spirochetes
were stained with the Live/Dead stain (Molecular Probes, Eugene, Oreg.) fol-
lowing the manufacturer’s instructions. The number of live spirochetes per mi-
croscope field was estimated by counting 10 fields and then determining the
average number of live bacteria per field. The proportion of bacteria killed in
each assay was determined by setting the number of spirochetes in MEM alone
as 100%.
Detection of C3 in serum and nymphal TGC. The proteins in NMS (0.2 l),
CDS (0.2 l), CD TGC (4 l), and WT TGC (4 l) were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The resolved proteins were
transferred onto polyvinylidene difluoride membranes and probed with a protein
detector Western blot kit (Kirkegaard & Perry Laboratories, Gaithersburg, Md.).
The membrane was blocked with the blocking solution provided in the kit and
probed with polyclonal goat anti-C3 antibodies (Sigma, St. Louis, Mo.) that
cross-react with human and mouse C3 components at a 1:400 dilution in the
blocking solution. The secondary antibody was a horseradish peroxidase-conju-
gated anti-goat immunoglobulin used at a 1:1,000 dilution. Antibody reactivity
was detected by the chemiluminescence method with the LumiGlo substrate
provided in the kit.
Assay for C3 deposition on spirochetes. Westchester strain-infected nymphs
were allowed to feed on naïve complement-sufficient and CD mice for 48 h.
Following feeding, the nymphs were removed with fine forceps and homogenized
in 40 l of GVB with 2 mM phenylmethylsulfonyl fluoride. In other experiments
109 Westchester strain spirochetes grown in culture were incubated with different
serum sources as described above, pelleted, washed twice with GVB, and resus-
pended in 1 ml of GVB. Five microliters of the suspended spirochetes (from
nymphs or culture) was spotted onto silylated slides (PGC Scientifics), air dried,
and acetone fixed. The spots were blocked with 5% fetal calf serum in PBS and
incubated with polyclonal goat anti-C3 antibodies (Sigma Chemical Co.) for 1 h
at room temperature. Following incubation, the slides were washed three times
with PBS and incubated with FITC-conjugated anti-goat antibodies. The slides
were then washed three times with PBS, air dried, mounted with Aqua-Poly-
mount, and viewed with a fluorescence microscope.
RESULTS
Spirochete number within nymphs feeding on WT and CD
mice. Spirochetes are mainly confined to the lumen of the gut
of infected nymphal ticks. When a nymph feeds on a naïve
mouse, the spirochetes multiply and increase in number. Given
that cultured Borrelia organisms activate complement even in
the absence of specific antibody, it is possible that the final
number of bacteria within a feeding nymph is a result of spi-
rochete multiplication as well as killing by complement in the
incoming blood meal. We carried out experiments to investi-
gate the effect of host complement on the load of spirochetes
within feeding nymphs. Nymphal ticks infected with B. burg-
dorferi were allowed to feed on naïve complement-sufficient
and CD mice for various time periods, and the spirochete
number inside each nymph was determined by immunoflu-
orescence. Spirochetes multiplied to equal numbers within
the nymphs independently of the presence or absence of a
functional complement system in the vertebrate host (Fig. 1).
Thus, host complement did not suppress spirochete growth in
feeding nymphal ticks.
The role of host complement in OspA-mediated transmis-
sion-blocking immunity. The studies described above proved
that in the absence of specific Borrelia antibody spirochete
growth within the feeding nymph was not sensitive to comple-
ment. We next set out to investigate if host complement was
capable of killing spirochetes if the incoming blood meal con-
tained specific antibodies against spirochetal antigens ex-
pressed in the nymphal tick gut. When animals vaccinated with
B. burgdorferi OspA are challenged with infected nymphs,
OspA antibodies in the incoming blood meal kill bacteria in
the nymphal tick gut and also block the movement of spiro-
chetes from the nymph to the host (9, 11). It is unclear if host
complement is absolutely required for the bactericidal effects
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of OspA antibody within the nymphal tick. We performed
experiments with groups of WT and CD mice immunized with
recombinant OspA (OspA-GST) and a control antigen (GST).
Spirochetes were killed within nymphs that fed on OspA-
immunized mice with and without a functional complement
system (Table 1). Furthermore, OspA antibodies blocked
transmission to both WT and CD mice (Table 1). Thus, in
hyperimmunized mice containing high levels of OspA antibody
an intact complement system in the host was not required to
kill spirochetes within feeding nymphs and block transmission
to mice.
Acquisition of B. burgdorferi by larval ticks. The life cycle of
the Lyme disease spirochete involves larval ticks acquiring
spirochetes from infected mice, the infected larvae molting to
the nymphal stage, and infected nymphal ticks transmitting
spirochetes to naïve mice. Having observed no role for com-
plement within infected nymphal ticks, we wanted to deter-
mine if host complement had an effect on the acquisition of
spirochetes by larval ticks. Larvae become infected as early as
24 h after feeding on an infected mouse (8). When a mouse
with an established B. burgdorferi infection is actively or pas-
sively immunized with OspA antibody, the infection in the
mouse is not cleared (10). However, OspA antibodies do in-
hibit the movement of spirochetes from the infected mouse to
feeding larval ticks (5, 8). Experiments were done to determine
if host complement had an effect on larval acquisition of spi-
rochetes in the presence and absence of OspA antibody.
CD and complement-sufficient mice were infected by placing
infected nymphs on the mice. Two weeks later, infection was
confirmed in all mice by serology. A polyclonal OspA antibody
(prepared in CD mice) or PBS was passively administered to
the infected mice, and 24 h later uninfected larval ticks were
placed on all the mice and allowed to feed to repletion. When
larvae recovered from WT and CD mice treated with PBS were
compared, no differences were observed in the number of
infected larvae or in the load of spirochetes within each in-
fected larva (Table 2). These results demonstrate that, in the
absence of specific antibody, host complement had no effect on
larval acquisition of spirochetes. When larvae recovered from
mice treated with OspA antibody were compared, a clear dif-
ference was observed between larvae that fed on WT mice and
those that fed on CD mice (Table 2). Larval infection was
more efficiently blocked by OspA antibody when the larvae fed
on mice with an intact complement system than when the
larvae fed on mice with no functional complement. These data
indicate that host complement does play a role in the OspA
antibody-mediated block in larval acquisition of spirochetes.
Is host complement active in the nymphal tick gut? From
the experiments with infected nymphal ticks, it was clear that
host complement did not have an effect on spirochetes within
nymphs. Borrelia in the nymphal gut may express genes that
confer a high level of resistance to complement. Alternatively,
spirochetes within the nymph may have been protected from
FIG. 1. Growth of B. burgdorferi within nymphs feeding on WT mice and CD mice. Homogenates were prepared from nymphs that had fed for
different time periods and stained with an FITC-conjugated anti-Borrelia antibody to determine the mean number of spirochetes within each
infected nymph as described in Materials and Methods. The data at each time point are based on four or five individual infected nymphs, and the
errors bars represent the standard deviations.
TABLE 1. Ability of OspA vaccination to block the transmission of
B. burgdorferi from nymphs to mice in the absence of complementa
Vaccine
antigen










GST  4/4  5/5
OspA-GST  0/4  0/5
a Mice deficient and sufficient in complement were immunized with OspA-
GST or GST alone and challenged with infected nymphal ticks.
b To assess the survival of spirochetes within the ticks that fed on immunized
mice, homogenates of the ticks were stained with anti-Borrelia FITC-conjugated
antibodies and counted under immunofluorescence. No spirochetes were ob-
served in the ticks that fed on OspA-GST-immunized mice, while the ticks that
fed on the GST-immunized mice were all found to be positive for the spirochetes.
c Results are number of mice infected/total number of mice.
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complement because complement in the blood meal is in an
inactive state. We performed experiments to determine if spi-
rochetes within feeding nymphs were more complement resis-
tant than were bacteria grown in culture. For this purpose we
used a procedure recently developed in our laboratory to pu-
rify B. burgdorferi from feeding nymphs (24). Similar numbers
of spirochetes (3  105 to 5  105) grown in culture or purified
from feeding nymphs were incubated with 10% NMS for 2 h at
37°C in a CO2 atmosphere. Under these conditions 42% of
the cultured bacteria and 95% of the bacteria purified from
nymphs were killed. Thus, bacteria within the nymph were not
especially resistant to serum-mediated killing; if at all, they
appeared to be more sensitive to mouse serum than were
spirochetes grown in culture.
Next, we performed experiments to test if host complement
in the blood meal was active within the nymph. Initially exper-
iments were done to determine if intact host C3 was present in
the blood meal. Nymphs were placed on WT and CD mice.
Protein extracts were prepared from NMS and CDS as well as
from nymphs that had partially fed (72 h) on WT and CD mice.
The extracts were resolved by sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis and probed with anti-C3 antibod-
ies in a Western blot assay. As expected full-length and cleaved
C3 were observed in NMS but not in CDS (Fig. 2). Full-length
C3 and cleaved C3 fractions were also observed in extracts
from nymphs that fed on WT mice (Fig. 2), indicating that
intact C3 was present within the nymph.
Borreliacidal assay for detection of complement activity in
the nymphal tick gut. Having confirmed the presence of intact
C3 protein in the nymphal tick gut, we performed experiments
to detect complement activity in the gut. Activity was measured
by an in vitro borreliacidal assay in which cultured spirochetes
were incubated with potential complement sources and specific
Borrelia antibody. When spirochetes were incubated with spe-
cific Borrelia antibody alone (no complement), approximately
13% of the spirochetes were killed (Fig. 3). When specific Bor-
relia antibody and a complement source (NMS) were added,
approximately 50% of the spirochetes were killed (Fig. 3).
Unlike NMS, gut contents from nymphs that had partially fed
on mice did not enhance the ability of antibody to kill spiro-
chetes, indicating that no active complement was present in the
guts of nymphs (Fig. 3). This conclusion was further strength-
ened when nymphal gut extracts were found to have an inhib-
itory effect on the ability of NMS and specific antibody to kill
spirochetes (Fig. 3). Thus, although C3 was present in the gut
of partially fed nymphs, no complement activity was observed.
Instead, nymphs appeared to have an activity that inhibited
complement activity in NMS.
Our conclusion that host complement was not active in the
nymphal gut was further supported by studies to detect the
deposition of C3 on the surface of spirochetes. When cultured
spirochetes were incubated with NMS or normal human se-
rum, C3 was deposited on the surface of the bacteria (Fig. 4A).
No C3 deposition was observed when cultured spirochetes
were incubated with heat-inactivated NMS or TGC from par-
tially fed ticks (data not shown). When homogenates from
partially fed infected nymphs were stained with the C3 anti-
body, no spirochetes were stained, indicating that C3 in the
blood meal was not deposited on the surface of the bacteria
within the gut (Fig. 4B). Although we did not observe spiro-
chete-shaped structures staining with the C3 antibody, we did
observed bright punctate material, which is probably free C3,
as it was also present in gut smears prepared from uninfected
ticks (Fig. 4B). Thus, although C3 is present in the blood meal
entering the gut (Fig. 2), we found no evidence that it was in a
state that permitted deposition on the surface of spirochetes.
DISCUSSION
The Lyme disease spirochete is exposed to host blood and
components of the host’s immune system in the gut of feeding
ticks (28). The present study was undertaken to determine if
spirochetes in the vector were sensitive to killing by host com-
plement in the presence and absence of specific Borrelia anti-
body. To our surprise, host complement proteins in the blood
meal did not influence spirochete numbers within infected
nymphs.
B. burgdorferi alters the expression of genes at different
stages in the vector and host, and it is plausible that the or-
ganisms in the tick gut may produce proteins that confer com-
plement resistance. Recent studies by several groups have im-
plicated the B. burgdorferi ERP family of surface proteins
in complement resistance (1, 14, 15, 30). Some ERPs are ex-
pressed by spirochetes in the nymphal tick gut, and the pres-
ence of these proteins on the bacterial surface may explain our
results (12). To test this idea, we purified B. burgdorferi bacte-
ria from partially engorged nymphs and then exposed them to
NMS. The bacteria purified from nymphs were serum sensitive
and, in fact, appeared to be more sensitive to serum than were
organisms grown in culture. Based on these results, it is un-
likely that innate serum resistance of spirochetes in the vector
accounts for our results.
Another potential explanation for our results is that host
TABLE 2. Differences in the abilities of OspA antibody to block
the acquisition of B. burgdorferi by larval ticks in the presence





No. of infected larvae
(degree of infectionb)
Fed on WT mouse 15 11 (4 high, 3 moderate, 4 low,
4 uninfected)
Fed on CD mouse 15 10 (2 high, 3 moderate, 5 low,
5 uninfected)
Study I
Fed on WT mouse  Abc 15 4 (4 low, 11 uninfected)
Fed on CD mouse  Ab 15 8 (1 high, 5 moderate, 2 low,
7 uninfected)
Study II
Fed on WT mouse  Ab 15 6 (2 high, 3 moderate, 1 low,
9 uninfected)
Fed on CD mouse  Ab 15 12 (4 high, 4 moderate, 4 low,
3 uninfected)
a Larval ticks were allowed to feed to repletion on B. burgdorferi-infected WT
or CD mice that were untreated or passively administered OspA antibody. Ten
days after feeding, the larvae were homogenized individually on slides and
stained with FITC-conjugated anti-Borrelia sp. antibodies. The results from two
independent passive OspA antibody transfer experiments are presented.
b Infection of the positive samples was graded based on the average number of
spirochetes per microscope field: 1 to 10, low; 11 to 50, moderate; more than 50,
high.
c Ab, antibody.
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complement is inactive in the nymphal tick gut, and our data
support this hypothesis. Although complement protein C3 was
deposited on the surface of spirochetes incubated with NMS,
we did not observe any C3 deposition on spirochetes incubated
with the gut contents of partially fed nymphs. Furthermore,
unlike NMS, gut contents from partially fed nymphs did not
enhance the bactericidal effects of Borrelia antibody in an in
vitro assay. In fact, nymphal TGC inhibited the bactericidal
effects of complement in NMS.
Why might host complement not be active within the vector?
The complement system involves the action of more than 23
host proteins, and it is possible that the environment within the
nymph may not be conducive for the coordinated activation of
these proteins. Alternatively, the nymph may actively produce
proteins that inhibit complement activity to protect tick epi-
thelial surfaces that come into contact with host blood as well
as to suppress host immunity at the site of tick feeding (25).
This hypothesis is supported by recent studies that have led to
the identification of two novel proteins in tick saliva that inhibit
host complement (7, 33). It is possible that these proteins
secreted into the host are also taken up in the blood meal
entering the nymphal tick gut, where they may protect tick
tissue as well as pathogens harbored by the tick.
Others have also studied the fate of host complement within
arthropod vectors, mainly mosquitoes (18, 32). Unlike in ticks,
complement was found to be active in the mosquito gut, at
least for the first several hours after the blood meal, and host
complement was observed to reduce the number of malarial
gametocytes infecting the mosquito. The observation that mos-
quitoes contain functional complement, unlike ticks, is not
surprising given the different feeding behavior and physiology
of these blood-feeding arthropods. Mosquitoes feed for a few
minutes and probably do not have to inhibit the host’s immune
responses, including complement, to the same extent as do
hard ticks that have to continuously feed on their host for many
days (2). Furthermore, the mosquito blood meal is digested in
the lumen of the gut, where the blood meal is enclosed in a
peritrophic membrane that protects the gut epithelial lining
from potentially harmful molecules in the blood meal (26). In
contrast ticks digest their blood meal intracellularly by phago-
cytosing gut content, and it is unclear if hard ticks have a
well-defined peritrophic matrix like mosquitoes do (31). The
peritrophic membrane and secreted digestive enzymes are
likely to protect mosquitoes’ tissue from host complement,
whereas the digestive strategy employed by ticks may require
the production of specific molecules by the vector for inacti-
vating host complement.
Our conclusion that host complement is inactive within the
vector contradicts a recent model proposed to explain the host
preference of different B. burgdorferi sensu lato species (16).
FIG. 2. Detection of C3 in serum and the gut contents of partially fed nymphs. Protein extracts were prepared from normal human serum
(NHS), NMS, CDS, WT TGC, and CD TGC and analyzed by Western blotting for the presence of C3 protein.
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B. valisiana, B. turdi, and certain strains of B. garinii are found
in enzootic cycles with birds as the main vertebrate reservoir,
whereas B. afzelii, B. bisseti, B. japonica, and most strains of
B. garinii appear to use rodents as the main reservoir host.
These host association patterns are also reflected in the com-
plement sensitivity of these Borrelia species, i.e., bird-associ-
ated species are resistant to bird complement and sensitive to
rodent complement, and the opposite is true for the rodent-
associated species. Kurtenbach and colleagues (17) have pro-
posed that sensitivity of spirochetes to host complement is a
key determinant of the host preferences of species in the B.
burgdorferi sensu lato complex. They also postulate that the
tick gut is the main site at which complement-mediated selec-
tion occurs, because the spirochetes come into close contact
with host blood in the vector. Our data indicating that host
complement is not active within the vector indicate that com-
plement-mediated selection is unlikely to occur within the vec-
tor. Rather, if complement sensitivity is responsible for the
host association patterns of different Borrelia species, the se-
lection is likely to occur once the spirochetes enter the host
and not in the vector (17).
Although our data point to complement being inactivated
within the nymphal tick gut, this hypothesis should be further
tested because the assays used here are all indirect measures of
complement activity within the gut. For example, the lack of
C3 deposition on spirochetes may be due to specific tick mol-
ecules binding to the spirochetes and not inactivation of the
complement cascade. Furthermore, the inhibitory activity in
TGC observed in vitro may be derived from a compartment
other than the lumen of nymphal tick gut and this activity may
not be relevant to events occurring within the gut lumen. At-
tempts are under way to purify this activity to determine its
structure and location of action within the tick.
B. burgdorferi OspA is the only Lyme disease vaccine that
has consistently proven efficacious in animal and human stud-
ies (22). The OspA vaccine protects hosts by generating anti-
bodies that enter the gut of the vector and block the movement
of spirochetes from the vector to the host. The exact mecha-
nism by which OspA antibodies block transmission is not
known. In vitro the borreliacidal effects of OspA antibodies are
greatly enhanced in the presence of complement (19, 29).
However, our results do not support a role for complement in
transmission-blocking immunity because spirochetes were
killed within infected nymphs feeding on OspA-vaccinated C3-
deficient mice. In these studies we used mice that had been
hyperimmunized with OspA, and the high levels of OspA an-
tibody may have masked a role for complement apparent at
lower titers of antibody. However, in preliminary studies with
low concentrations of OspA antibody we have observed no role
FIG. 3. In vitro borreliacidal assay to detect active complement in nymphal tick gut extracts. Spirochetes from culture were incubated with
specific anti-Borrelia antibody alone (Ab), NMS and specific antibody (NMS  Ab), gut contents from nymphs feeding on WT mice and specific
antibody (WT TGC  Ab) or NMS, and gut contents from nymphs feeding on CD mice and specific antibody (CD TGC  NMS  Ab). The data
are presented as the percentages of surviving spirochetes in comparison to a control not treated with antibody or complement source. The asterisk
indicates that the NMS  Ab group had significantly fewer surviving spirochetes than did the other three groups (analysis of variance test followed
by Tukey highest significant difference test, P  0.05). The Ab-alone, WT TGC  Ab, and CD TGC  NMS  Ab groups were not significantly
different from one another.
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for complement in transmission-blocking immunity (C. Gipson
and A. de Silva, unpublished data).
Our conclusion that host complement is inactive in the vec-
tor also has implications for developing arthropod-specific
transmission-blocking vaccines against Borrelia and other tick-
borne pathogens. The development and evaluation of these
vaccines should not be based on eliciting antibody responses
that fix complement. Rather, the ability of antibodies to kill the
pathogen of interest in the absence of complement or the
ability of antibody to specifically interfere with interactions
between the vector and pathogen should be given precedence.
During the natural transmission cycle of the Lyme disease
spirochete, larval ticks acquire the infection and nymphs trans-
mit the infection (6). In addition to the effects on nymphal
FIG. 4. Indirect immunofluorescence assay to detect C3 deposition on the surface of B. burgdorferi. C3 in blood entering the vector was not
deposited on the surface of spirochetes. (A) Cultured spirochetes were incubated with buffer alone, NMS, or normal human serum (NHS). The
samples were fixed and stained with an anti-Borrelia polyclonal antibody or anti-C3 polyclonal antibody. Spirochetes were stained with the C3
antibody when they were exposed to NMS or NHS. (B) Infected and uninfected nymphs were allowed to partially engorge on a WT mouse, and
the tick guts were homogenized and stained with an anti-Borrelia polyclonal antibody or anti-C3 polyclonal antibody. Spirochetes in the nymphal
tick gut were not stained with the C3 antibody. The punctate staining observed with the C3 antibody in infected and uninfected nymphs probably
represents free C3 in the blood meal.
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transmission, OspA antibody also blocks larvae from acquiring
infections from infected mice (8). Here we report that the
effect of OspA antibody on larval acquisition was enhanced in
the presence of a functional complement system in the host.
Thus, the effects of OspA antibody on nymphal transmission
and larval acquisition appear to be based on fundamentally
different mechanisms, one independent of and the other de-
pendent on host complement. Larval ticks and nymphal ticks
may inactivate host complement to different extents. Alter-
nately, the spirochetes en route from the host to larvae may
produce OspA in the host, leading to opsonization and com-
plement-mediated clearance in the host before the spirochetes
ever get into the vector. Further studies are needed to under-
stand the exact mechanisms by which antibody blocks the
movement of spirochetes between vector and host.
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